GlassScriptPhysician profile
Mary T Labowsky
NPI 1326570565
$775.70
in general payments reported to CMS, 2019-2025
7 companies · $74.55 in 2025
The $74.55 reported for 2025 was less than what a typical Neuro-Ophthalmology provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.63 · 2021: $40.94 · 2022: $106 · 2023: $416 · 2024: $111 · 2025: $74.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $223.48 | 2020-2024 | Hydrus Microstent, Clareon |
| Astellas Pharma US INC | $137.03 | 2023 | |
| Bausch & Lomb Americas INC. | $107.29 | 2023 | Stellaris |
| Horizon Therapeutics Plc | $106.36 | 2022 | |
| Oculus Surgical INC. | $86.05 | 2023 | |
| Argenx US, INC. | $74.55 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $40.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Labowsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.